Effect of the Echinocandin Caspofungin on Expression of Candida albicans Secretory Aspartyl Proteinases and Phospholipase In Vitro
- 1 September 2002
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (9) , 3096-100
Abstract
Although the echinocandin caspofungin primarily inhibits the synthesis of cell wall 1,3-β- d -glucan, its fungicidal activity could also potentially perturb the expression of virulence factors involved in the ability of Candida albicans to cause infection. Expression of the C. albicans secretory aspartyl proteinase ( SAP ) and phospholipase B ( PLB ) virulence genes was determined by reverse transcription-PCR after the addition of caspofungin to cells grown for 15 h in Sabouraud dextrose broth. In cells that remained viable, expression of SAP1 to SAP3 , SAP7 to SAP9, and PLB1 was unaltered after exposure to fungicidal concentrations (4 to 16 μg/ml) of caspofungin over a period of 7 h. However, expression of SAP5 increased steadily beginning 1 h after exposure to caspofungin. These results indicate that caspofungin is rapidly fungicidal against C. albicans , before any suppression of SAP or PLB1 gene expression can occur.Keywords
This publication has 49 references indexed in Scilit:
- Evidence for Differential Expression ofCandida albicansVirulence Genes during Oral Infection in Intact and Human Immunodeficiency Virus Type 1–Transgenic MiceThe Journal of Infectious Diseases, 2002
- Update on antifungals targeted to the cell wall: focus on β-1,3-glucan synthase inhibitorsExpert Opinion on Investigational Drugs, 2001
- Differential regulation of SAP8 and SAPS, which encode two new members of the secreted aspartic proteinase family in Candida albicansMicrobiology, 1998
- Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.Diagnostic Microbiology and Infectious Disease, 1998
- Overexpression of Candida albicans secretory aspartyl proteinase 2 and its expression in Saccharomyces cerevisiae do not augment virulence in miceMicrobiology, 1998
- Potential new antifungal agentsCurrent Opinion in Infectious Diseases, 1997
- Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicansMolecular Microbiology, 1994
- ANTIBIOTICS THAT INHIBIT FUNGAL CELL WALL DEVELOPMENTAnnual Review of Microbiology, 1994
- Pneumocandin antifungal lipopeptides. The phenolic hydroxyl is required for 1,3-β-glucan synthesis inhibition.Bioorganic & Medicinal Chemistry Letters, 1993
- Experimental oral candidosis in the mouse: microbiologic and histologic aspectsJournal of Oral Pathology & Medicine, 1990